Catheter Precision Expands LockeT Device to Ireland's Largest Electrophysiology Center
核心洞察
Catheter Precision secured its first purchase order for LockeT (搜索) at Mater Private Hospital (搜索) in Dublin, Ireland's largest electrophysiology center performing over 1,000 EP procedures annually.
The suture retention device demonstrated rapid adoption with 52 staff members trained in just two days, highlighting its intuitive design and operational efficiency.
This expansion marks Ireland as the eighth European country to adopt LockeT (搜索) since receiving CE Mark approval, strengthening the company's global electrophysiology market position.
Catheter Precision, Inc. (VTAK - NYSE/American) has successfully implemented its LockeT (搜索) suture retention device at Mater Private Hospital (搜索) in Dublin, Ireland, securing the company's first purchase order and multi-year commitment from Ireland's largest electrophysiology center. The milestone represents a significant advancement in the company's global expansion strategy and reinforces its commitment to improving procedural safety and efficiency in cardiac care.
Strategic Partnership with Leading EP Center
Mater Private Hospital (搜索) stands as Ireland's largest electrophysiology center, performing over 1,000 EP procedures annually, making it a key institution for arrhythmia treatment and innovation. The hospital's adoption of LockeT (搜索) validates the device's clinical utility in high-volume cardiac procedures.
Prof. Gábor Széplaki, a leading electrophysiologist and key opinion leader in Europe, has been instrumental in introducing LockeT (搜索) to Mater Private Dublin. His commitment to innovation ensures LockeT will play a vital role in advancing EP care at the center by demonstrating the product's ability to streamline workflows.
Rapid Implementation and Staff Adoption
The device's implementation showcased remarkable efficiency, with the chief nurse personally training 52 staff members in just two days. This rapid onboarding process demonstrates LockeT (搜索)'s intuitive design and operational efficiency, critical factors for successful adoption in busy clinical environments.
Fatih Ayoglu, European Sales Manager at Catheter Precision, emphasized the significance of this partnership: "Partnering with Mater Private Dublin is a major achievement for Catheter Precision. As Ireland's largest EP center, their multi-annual commitment to LockeT (搜索) validates our technology and strengthens our position in the global electrophysiology market."
Device Technology and Regulatory Status
LockeT (搜索) is a suture retention device specifically designed to assist in wound closure after percutaneous venous punctures. The device holds Class 1 registration with the FDA and has received CE Mark approval, enabling its use across European markets. This regulatory foundation supports the company's expansion strategy across international markets.
European Market Expansion
The implementation at Mater Private Hospital (搜索) marks Ireland as the eighth European country to adopt LockeT (搜索) since the device received CE Mark approval. This expansion underscores Catheter Precision's focus on expanding its footprint in international markets and driving adoption of technologies that improve clinical outcomes.
Catheter Precision positions itself as an innovative U.S.-based medical device company focused on developing groundbreaking technology for electrophysiology procedures through physician collaboration and continuous product advancement. The company's mission centers on bringing new solutions to market to improve the treatment of cardiac arrhythmias.